Retinal Imaging in Neurodegenerative Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDuke University

About this trial

This study aims to develop and evaluate biomarkers using non-invasive optical coherence tomography (OCT) and OCT angiography (OCTA) as well as ultra-widefield (UWF) fundus photography to assess the structure and function of the retinal and choroidal microvasculature and structure in persons with mild cognitive impairment (MCI) and Alzheimer's Disease (AD), Parkinson's Disease (PD), or other neurodegenerative disease, diseases as outlined.

Eligibility criteria

Qualifiers

Adults with neurodegenerative disease ((MCI, PD, AD, FTD, DLB, ALS, MS, HD, TBI, concussion, PTSD and other neurodegenerations as well as Down Syndrome)

Adults without neurodegenerative disease

Disqualifiers

Inability to cooperate with or complete testing or other neurologic or age- related ocular conditions that would impact image acquisition.

Eyes that have had intraocular surgery, other than cataract surgery.

Trial design

Treatments tested in this trial

  • Retinal and Choroidal Imaging

Treatment groups

2,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Duke University

Lead sponsor

University of Edinburgh in Scotland

Collaborator

Tan Tock Seng Hospital in Singapore

Collaborator

Queens University of Belfast United Kingdom

Collaborator